Company performance
Add to research
Current Price
as of Feb 14, 2025$19.95
P/E Ratio
N/A
Market Cap
$2.52B
Description
Add to research
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.
Metrics
Add to research
Overview
- HQPasadena, CA
- SectorHealth Technology
- IndustryBiotechnology
- TickerARWR
- Price$19.95+4.40%
Trading Information
- Market cap$2.52B
- Float93.07%
- Average Daily Volume (1m)2,602,946
- Average Daily Volume (3m)2,062,578
- EPS-$5.15
Company
- Revenue$2.50M
- Rev growth (1yr)-29.60%
- Net income-$173.08M
- Gross margin-109.40%
- EBITDA margin-6,247.08%
- EBITDA-$156.18M
- EV$2.67B
- EV/Revenue1,067.90
- P/EN/A
- P/S996.29
- P/B47.64
- Debt/Equity1,658.23
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Factset